Further steps in the clinical development of FOL-005 is to go through with phase II and phase III trials.
In parallel to our clinical development of FOL-005 we are also developing a new user friendly formulation. Prototypes have been developed and have been tested in vast studies and we have chosen a cosmetically appealing direct-to-scalp formulation. The new product has been shown to effectively deliver the active substance into the skin and the hair follicles. The chosen formulation has also been shown to be stable in long-term storage. The final product will now be tested in phase II trials, followed by phase III trials before being approved and launched on the market.